The intricate relationships among TNF‐α, IL‐6, CCL2, and TGF‐β through positive feedback loops and synergistic interactions create a persistent fibrotic environment, suggesting that a multifaceted therapeutic approach may be necessary to address liver fibrosis effectively. The gene discussed is TNF; the disease is Hepatic fibrosis.